Lucy Scientific Discovery Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LSDI research report →
Price Chart
About the company
Lucy Scientific Discovery Inc. focuses on the entire lifecycle of psychedelic products, from their initial research and development to their production and subsequent market release. The company's offerings include fundamental biological raw materials, unprocessed extracts, a variety of psychotropic compounds, and critical active pharmaceutical ingredients (APIs).
- CEO
- Richard D. Nanula
- IPO
- 2023
- Employees
- 2
- HQ
- Victoria, BC, CA
Get TickerSpark's AI analysis on LSDI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $906.91K
- P/E
- -0.72
- PEG
- 0.01
- P/S
- 128.68
- P/B
- 1.40
- EV/EBITDA
- -0.18
- Div Yield
- 0.00%
- Gross Margin
- 36.15%
- Op Margin
- -82919.74%
- Net Margin
- -127532.01%
- ROE
- 18147.32%
- ROIC
- -90.36%
Latest fiscal year · YoY change
- Revenue
- $7.05K+0.0%
- Gross Profit
- $2.55K+0.0%
- Op Income
- $-5,844,183
- Net Income
- $-8,988,456-45.5%
- EPS
- $-0.71-86.8%
- OCF Growth
- -76.4%
- FCF Growth
- -86.2%
- 52W High
- $12.80
- 52W Low
- $0.44
- 50D MA
- $0.88
- 200D MA
- $2.28
- Beta
- 0.71
- RSI (14)
- 25
- Avg Volume
- 1.23M
No earnings-call transcripts are available for LSDI yet.
- Free Float
- 69.4%
- Shares Outstanding
- 1.76M
- Float Shares
- 1.23M
Buy/sell ratio 0.80. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 13, 23 | McElvany Christopher | other | 366,187 |
| Feb 13, 23 | McElvany Christopher | other | 118,403 |
| Feb 13, 23 | McElvany Christopher | other | 500,000 |
| Feb 13, 23 | Kazeminy Assad J | other | 85,000 |
| Feb 13, 23 | Susin Livio | other | 9,309 |
| Feb 8, 23 | Kazeminy Assad J | other | 0 |
| Feb 8, 23 | NANULA RICHARD D | other | 0 |
| Feb 8, 23 | Zasitko Brian | other | 0 |
| Feb 8, 23 | Susin Livio | other | 0 |
| Feb 8, 23 | Susin Livio | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our LSDI coverage
Recent articles, reports, and earnings notes.
No research on LSDI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LSDI report →Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
businesswire.com · May 28
Why Is Lucy Scientific Discovery (LSDI) Stock Up 227% Today?
investorplace.com · May 16
Lucy Scientific Discovery Inc. Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
businesswire.com · Feb 16
Lucy Scientific Discovery's Alternative Mental Health Treatments to Provide Opportunity to Improve Mental Health
globenewswire.com · Oct 18
Lucy Scientific Discovery (NASDAQ: LSDI) Acquisitions Create ‘Golden Opportunity' for Growth, Success
globenewswire.com · Sep 26
Lucy Scientific Discovery (NASDAQ: LSDI) Leverages Power of M&A to Capitalize on Synergistic Growth
globenewswire.com · Sep 20
Lucy Scientific Discovery Expands its Reach in the Global Wellness Market with BlueSky Wellness Acquisition
accesswire.com · Sep 12
Lucy Scientific Discovery Inc. Announces Acquisition of BlueSky Wellness Inc. in All-Stock Transaction
globenewswire.com · Sep 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.